|Minimum Order Quantity||3 Bottle|
|Dose/Strength (mg or ml)||400 mg sofosbuvir + 90 mg Ledipasvir|
|Pack Size||28 Tablets|
Product Name: Hepcinat LP
- Trade Name: : HEPCINAT-LP
- Drug Form: Medicine is available in the form of Tablets
- Generic Name: The generic name is Ledipasvir
- Active Ingredients: Ledipasvir 90mg and Sofosbuvir 400mg
- Packing: – Pack of 28 Tablets
Hepatitis C is a viral infection that causes inflammation of the liver. Genotypes are used to identify particular strains of HCV which are based upon differences in particular regions of the viral genome. Hepcinat-LP Tablet is a prescription medicine containing Ledipasvir (90mg) a viral NS5A inhibitor and Sofosbuvir (400mg) a nucleotide inhibitor of the viral RNA polymerase.
The international brand name of this medicine is Harvoni that provides effective treatment in Hepatitis C Genotype 1 with a cure rate ranging between 94% to 99%. Hepcinat-LP helps prevent Hepatitis C Virus infection from multiplying in your body by weakening the virus and inhibiting its reproduction and replication.
How HEPCINAT-LP TABLET works
Ledipasvir and Sofosbuvir work by lowering a load of hepatitis C virus in the body and removing the virus from the blood over a period of time.
Side effects :-
The following is a list of possible side-effects that may occur from all constituting ingredients of HEPCINAT-LP TABLET. This is not a comprehensive list. These side-effects are possible, but do not always occur.
- Headache 2. Tired feeling. 3. Lower back pain.